Oligometastatic Adenocarcinoma

histology

Identifier: CI-CAN-00006153
Entity page: /cancer/oligometastatic-adenocarcinoma ↗
Edges: 9

Neighbours: 5 drugs4 trials
Drawn: 9 of 9 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Oligometastatic Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived5 of 5
→ investigated in trials for	Capecitabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Oligometastatic Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants	—

Oligometastatic Adenocarcinoma studied in …STUDIED_INderived4 of 4
→ studied in	NCT04248452Phase 3 · active not recruiting Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Oligometastatic Esophageal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04975516Phase 2 · terminated Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Oligometastatic Pancreatic Ductal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07269626Phase 2 · recruiting PULSAR in Systemic Therapy for Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Oligometastatic Pancreatic Ductal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05303714Phase 3 · recruiting PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Oligometastatic Gastric Adenocarcinoma	1	Observed	clinicaltrials	graph →

Oligometastatic Adenocarcinoma studied in …STUDIED_INderived4 of 4

→ studied in

NCT04248452Phase 3 · active not recruiting

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Oligometastatic Esophageal Adenocarcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT04975516Phase 2 · terminated

Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Oligometastatic Pancreatic Ductal Adenocarcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT07269626Phase 2 · recruiting

PULSAR in Systemic Therapy for Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Oligometastatic Pancreatic Ductal Adenocarcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT05303714Phase 3 · recruiting

PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Oligometastatic Gastric Adenocarcinoma

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains